Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, Sayer H, Jung W, Duerk HA, Salwender H, Wandt H, Bassermann F, Gramatzki M, Rösler W, Wolf HH, Brugger W, Engelhardt M, Fischer T, Liebisch P, Straka C (2017)

Publication Type: Journal article

Publication year: 2017

Journal

DOI: 10.1038/leu.2017.83

Abstract

Leukemia accepted article preview online, 15 March 2017. doi:10.1038/leu.2017.83.

Authors with CRIS profile

Involved external institutions

Klinikum Nürnberg Germany (DE) Schön Kliniken Germany (DE) Universitätsklinikum Ulm Germany (DE) Otto-von-Guericke-Universität Magdeburg Germany (DE) Albert-Ludwigs-Universität Freiburg Germany (DE) Schwarzwald-Baar Klinikum Germany (DE) Universitätsklinikum Halle (Saale) Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) Technische Universität München (TUM) Germany (DE) Asklepios Kliniken Germany (DE) St. Marien-Hospital Hamm Germany (DE) Universitätsklinikum Göttingen Germany (DE) Universitätsklinikum Jena Germany (DE) Klinikum Oldenburg Germany (DE) Universitätsklinikum Münster Germany (DE) acromion GmbH Germany (DE) Janssen-Cilag GmbH Germany (DE) Julius-Maximilians-Universität Würzburg Germany (DE)

How to cite

APA:

Einsele, H., Knop, S., Vogel, M., Mueller, J., Kropff, M., Metzner, B.,... Straka, C. (2017). Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma. Leukemia. https://dx.doi.org/10.1038/leu.2017.83

MLA:

Einsele, H., et al. "Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma." Leukemia (2017).

BibTeX: Download